Iterum Therapeutics (ITRM)
(Delayed Data from NSDQ)
$0.71 USD
-0.02 (-2.49%)
Updated Aug 4, 2025 04:00 PM ET
After-Market: $0.72 +0.01 (0.87%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth C Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Iterum Therapeutics PLC's dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ITRM 0.71 -0.02(-2.49%)
Will ITRM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ITRM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ITRM
ITRM Posts Updates From FDA Advisory Meeting for UTI Drug, Stock Down
ITRM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ITRM
Iterum Therapeutics Q2 Earnings Preview
Here are the major earnings before the open Tuesday
Insights Ahead: Iterum Therapeutics's Quarterly Earnings
Iterum Therapeutics to Report Second Quarter 2025 Financial Results on August 5, 2025 | ITRM ...
12 Health Care Stocks Moving In Wednesday's After-Market Session